E42. Patterns of Tocilizumab Use and Safety in Patients with Rheumatoid Arthritis: Interim Results from Act-Up: A Multinational Observational Study
Auteur
Haraoui, Boulos. Rheumatology Department, Institut de Rhumatologie, Montreal, QC, Canada, Médico Reumatólogo, Hospital Militar Central, Buenos Aires, Argentina, Department of Rheumatology, Skåne University Hospital Malmö, Lund University, Sweden, University of Pécs, Medical Centre, Pécs, Hungary, Rheumatology Department, Royal Perth Hospital, Perth, Medical Department, Roche Products Pty Limited, Dee Why, Australia, Medical Department, F Hoffmann-La Roche, Basel, Switzerland and University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy
Casado, Gustavo. Rheumatology Department, Institut de Rhumatologie, Montreal, QC, Canada, Médico Reumatólogo, Hospital Militar Central, Buenos Aires, Argentina, Department of Rheumatology, Skåne University Hospital Malmö, Lund University, Sweden, University of Pécs, Medical Centre, Pécs, Hungary, Rheumatology Department, Royal Perth Hospital, Perth, Medical Department, Roche Products Pty Limited, Dee Why, Australia, Medical Department, F Hoffmann-La Roche, Basel, Switzerland and University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy
Theander, Elke. Rheumatology Department, Institut de Rhumatologie, Montreal, QC, Canada, Médico Reumatólogo, Hospital Militar Central, Buenos Aires, Argentina, Department of Rheumatology, Skåne University Hospital Malmö, Lund University, Sweden, University of Pécs, Medical Centre, Pécs, Hungary, Rheumatology Department, Royal Perth Hospital, Perth, Medical Department, Roche Products Pty Limited, Dee Why, Australia, Medical Department, F Hoffmann-La Roche, Basel, Switzerland and University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy
Czirják, Laszlo. Rheumatology Department, Institut de Rhumatologie, Montreal, QC, Canada, Médico Reumatólogo, Hospital Militar Central, Buenos Aires, Argentina, Department of Rheumatology, Skåne University Hospital Malmö, Lund University, Sweden, University of Pécs, Medical Centre, Pécs, Hungary, Rheumatology Department, Royal Perth Hospital, Perth, Medical Department, Roche Products Pty Limited, Dee Why, Australia, Medical Department, F Hoffmann-La Roche, Basel, Switzerland and University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy
Taylor, Andrew. Rheumatology Department, Institut de Rhumatologie, Montreal, QC, Canada, Médico Reumatólogo, Hospital Militar Central, Buenos Aires, Argentina, Department of Rheumatology, Skåne University Hospital Malmö, Lund University, Sweden, University of Pécs, Medical Centre, Pécs, Hungary, Rheumatology Department, Royal Perth Hospital, Perth, Medical Department, Roche Products Pty Limited, Dee Why, Australia, Medical Department, F Hoffmann-La Roche, Basel, Switzerland and University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy
Button, Peter. Rheumatology Department, Institut de Rhumatologie, Montreal, QC, Canada, Médico Reumatólogo, Hospital Militar Central, Buenos Aires, Argentina, Department of Rheumatology, Skåne University Hospital Malmö, Lund University, Sweden, University of Pécs, Medical Centre, Pécs, Hungary, Rheumatology Department, Royal Perth Hospital, Perth, Medical Department, Roche Products Pty Limited, Dee Why, Australia, Medical Department, F Hoffmann-La Roche, Basel, Switzerland and University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy
Hinsch Gylvin, Lykke. Rheumatology Department, Institut de Rhumatologie, Montreal, QC, Canada, Médico Reumatólogo, Hospital Militar Central, Buenos Aires, Argentina, Department of Rheumatology, Skåne University Hospital Malmö, Lund University, Sweden, University of Pécs, Medical Centre, Pécs, Hungary, Rheumatology Department, Royal Perth Hospital, Perth, Medical Department, Roche Products Pty Limited, Dee Why, Australia, Medical Department, F Hoffmann-La Roche, Basel, Switzerland and University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy
Caporali, Roberto. Rheumatology Department, Institut de Rhumatologie, Montreal, QC, Canada, Médico Reumatólogo, Hospital Militar Central, Buenos Aires, Argentina, Department of Rheumatology, Skåne University Hospital Malmö, Lund University, Sweden, University of Pécs, Medical Centre, Pécs, Hungary, Rheumatology Department, Royal Perth Hospital, Perth, Medical Department, Roche Products Pty Limited, Dee Why, Australia, Medical Department, F Hoffmann-La Roche, Basel, Switzerland and University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy
Type de document
Postprint
Langue
Anglais
Publié dans
Rheumatology, 2015, vol. 54, p. i188-i188. Oxford University Press